Tolerance to tumor cell-expressed molecules and selection of cells that evade immune surveillance during tumor progression create effective barriers to immunotherapy. We investigated the cytotoxic T-lymphocyte response to simian virus 40 (SV40) tumor (T/t) antigen in two lineages of transgenic mice bearing the same rat insulin promoter-SV4O T/t antigen (RIP Tag) hybrid gene. RIP1-Tag2 mice, which express Tag as embryos, are tolerant to Tag, whereas RIPl-Tag4 mice, which express the transgene in pancreatic islet 13 cells several weeks after birth and develop insulinomas, can Expression ofthe rat insulin promoter (RIP)-Tag transgene in mice leads to pancreatic (3-cell hyperplasia, progression into highly vascularized (3-cell tumors (insulinomas), and premature death (5). Based on the antibody response to Tag, one of these transgenic lines, RIPl-Tag2, which expresses Tag in multiple neuroendocrine-derived cells and pancreatic (3 cells during fetal life (6), was deemed tolerant to the transgene product, whereas a second lineage, RIP1-Tag4, which reportedly expresses the transgene 10-12 weeks after birth (7), was Tag-responsive. Mice ofthe RIP1-Tag4 lineage, and not those of the RIP1-Tag2 lineage, mount a normal Tag-specific antibody response after immunization with Tag (7, 8) . However, it is the cytotoxic T-lymphocyte (CTL) response, not the B-cell response, to Tag that correlates with the control of Tag-induced tumor growth (9). We therefore investigated the CTL response to Tag in RIP1-Tag2 and RIP1-Tag4 mice. We report that RIP1-Tag2 mice are tolerant to Tag, but RIP1-Tag4 mice can generate an active Tagspecific CTL response upon infection with SV40. Immunization before, but not after, the onset oftransgene expression significantly delayed the development of Tag-induced insulinomas in RIP1-Tag4 mice, suggesting that expression of the transgene product in pancreatic (3 cells induces peripheral immunologic unresponsiveness. Although the lifespan of the effectively immunized mice was significantly extended, they too eventually succumbed to Tag-induced insulinomas.
Tag-specific T cells are rendered unresponsive in vivo in RIP1-Tag4 mice and that the establlshment of this unresponsiveness to Tag can be prevented by SV40 immunization only before the onset of the transgene expression. In the older, succssully immunized mouse, decreased immune surveillance and selection of cells with down-regulation of major histocompatibility complex class I expression most likely set the stage for insulinoma development.
Tumor cells can be distinguished immunologically from normal cells of the same histotype under experimental conditions, but the immune control of autochthonous tumors is not a reliable treatment modality. Transgenic mouse lineages in which expression ofa single oncogene is targeted to a specific cell type, but at different times in development, provide a way to examine the role of host immune surveillance. Our work has centered on mice infected with simian virus 40 (SV40) or transgenic for the SV40 early region which encodes the intracellular tumor (T/t) antigen (Tag). Tag induces continuous proliferation (1) and by mutation and selection, eventual tumor formation in animals that are specifically unable to respond to Tag (2) (3) (4) .
Expression ofthe rat insulin promoter (RIP)-Tag transgene in mice leads to pancreatic (3-cell hyperplasia, progression into highly vascularized (3-cell tumors (insulinomas), and premature death (5) . Based on the antibody response to Tag, one of these transgenic lines, RIPl-Tag2, which expresses Tag in multiple neuroendocrine-derived cells and pancreatic (3 cells during fetal life (6) , was deemed tolerant to the transgene product, whereas a second lineage, RIP1-Tag4, which reportedly expresses the transgene 10-12 weeks after birth (7), was Tag-responsive. Mice ofthe RIP1-Tag4 lineage, and not those of the RIP1-Tag2 lineage, mount a normal Tag-specific antibody response after immunization with Tag (7, 8) . However, it is the cytotoxic T-lymphocyte (CTL) response, not the B-cell response, to Tag that correlates with the control of Tag-induced tumor growth (9) . We therefore investigated the CTL response to Tag in RIP1-Tag2 and RIP1-Tag4 mice. We report that RIP1-Tag2 mice are tolerant to Tag, but RIP1-Tag4 mice can generate an active Tagspecific CTL response upon infection with SV40. Immunization before, but not after, the onset oftransgene expression significantly delayed the development of Tag-induced insulinomas in RIP1-Tag4 mice, suggesting that expression of the transgene product in pancreatic (3 cells induces peripheral immunologic unresponsiveness. Although the lifespan of the effectively immunized mice was significantly extended, they too eventually succumbed to Tag-induced insulinomas.
MATERIALS AND METHODS
Mice. C57BL/6J and nu/nu mice were purchased from The Jackson Laboratory. The Tag-transgenic mouse lineages RIP1-Tag2 and RIP1-Tag4 were provided by Douglas Hanahan (University of California, San Francisco, CA) and were backcrossed onto the C57BL/6J background. P2-Microglobulin (p2m)-deficient mice were obtained from RudolfJaenisch (Whitehead Institute, Cambridge, MA). Cell Lines. C57SV (H-2b), KD2SV (H-2d), and 1308.1 (H-2b) are SV40-transformed mouse cell lines derived from embryo, kidney, and thymic stroma, respectively (10, 11) . MC57G (H-2b) is a stable cell line derived from a methylcholanthreneinduced tumor of a C57BL/6 mouse (12).
51Cr-Release Assay. Mice were primed in vivo by injecting 107 infectious units of SV40 into the hind footpads. Splenocytes obtained 7 days later, or those from unprimed mice, were cocultivated with irradiated (10,000 rads; 1 rad = 0.01 Gy) syngeneic SV40-transformed stimulator cells (C57SV) at a ratio of 166:1. On day 6 of incubation, splenocytes were collected and incubated with 51Cr-labeled 1308.1 target cells (104) in triplicate at the specified ratios for 4 hr as described (10) .
Isolation of Pancreatic Islets and Preparation of Single Islet
Cells. Pancreatic islets were isolated from RIP1-Tag and control (C57BL/6J) mice by collagenase P (Boehringer Mannheim) digestion followed by discontinuous Ficoll (Sigma) gradient centrifugation (13) . A single-cell suspension Proc. Natl. Acad. Sci. USA 91 (1994) 3917 from the pancreatic islets was prepared by trypsin digestion (13 was extracted from RIP1-Tag mice as described (16) . cDNA synthesis and the preparation for PCR amplification were performed as described (16) . Samples were placed in a thermal cycler (Perkin-Elmer) for 30-40 cycles of940C for 30 sec, 60'C for 30 sec, and 720C for 1 min. Oligodeoxynucleotideprimersusedwere 3' Tagprimer(5'-GACACTCTATGC-CTGTGTGG-3'), 5' Tag primer (5'-GTCTTGAAAGGAGT-GCCTGG-3'), 3' actin primer (5'-CTCTTTGATGTCACG-CACGATTTC-3') and 5' actin primer (5'-GTGGGCCGCT-CTAGGCACCAA-3').
Analysis of Blood Glucose. Blood samples were obtained from the tails of mice at biweekly intervals. Blood glucose was determined with the Chemstrip bG and an Accu-Chek II blood glucose monitor (Boehringer Mannheim). RESULTS RIP1-Tag4, but Not RIPl-Tag2, Mice Mount a CTL Response to Tag. To evaluate the ability of RIP1-Tag mice to mount a Tag-specific CTL response, RIPl-Tag2 mice, RIPKTag4 mice, and their transgene-negative littermates were primed in vivo by abortive infection with SV40 and evaluated for Tag-specific cytotoxicity. RIPl-Tag4 mice at any age from 3 weeks to 8 months generated a vigorous CTL response comparable to that observed in age-matched nontransgenic mice, whereas splenocytes from RIP1-Tag2 mice at any age did not lyse the SV40-transformed target cells ( Fig. 1 A and B, respectively). Splenocytes from unprimed RIP1-Tag4 mice and their negative littermates were cocultured with C57SV cells and assayed for Tag-specific CTLs. Cells from nontransgenic mice did not lyse SV4O-transformed target cells, but splenocytes from RIP1-Tag4 mice at .6 months of age specifically lysed SV4O-transformed target cells, although the lysis was less than that generated from in vivo priming (Fig. 2) . Thus, RIPl-Tag4 mice mount a Tag-specific CTL response when the tumor antigen is presented by traditional antigen-presenting cells-i.e., upon SV40 infection-and show evidence of in vivo priming by endogenous antigens at an older age (>6 months). RlP1-Tag2 mice appear profoundly tolerant to Tag. SV40 Infection Prior to Endogenous Tag Expression Significantly Delays Tumor Development in RIP1-Tag4 Mice. Because RIP1-Tag4 mice mounted an active CTL response upon Tag stimulation, we hypothesized that Tag immunization of these mice by a conventional route might eliminate Tagexpressing ,B cells as they arose in the host, precluding insulinoma development. To test this hypothesis, RIP1-Tag4 mice at 3, 6, and 9 weeks of age were abortively infected with 107 infectious units of SV40, and insulinoma growth was monitored by measuring blood glucose levels biweekly throughout the lifespan of the animals. A single injection of SV40 into 3-week-old RIP1-Tag4 mice significantly delayed tumor development by >1 year, and multiple SV40 injections at 6-week intervals, beginning at 3 weeks of age, resulted in long-term suppression of tumor appearance ( Table 1 ). The efficacy of immunization decreased with the age of the mice. While the average lifespan of RIP1-Tag4 mice after a single SV40 injection at 3 weeks of age was 622 days, the lifespan ofmice immunized at 6 weeks ofage was reduced to 487 days. When 9-week-old mice were immunized, the average lifespan was 324 days, which is not significantly different from the (Fig. 3A) , although islet hyperplasia was evident (Fig. 3B) . Fewer than 10% of islets were ever infiltrated with lymphocytes in these mice, in contrast with the findings for the same lineage in another colony (7) . In RIP-Tag4 mice immunized at 3 or 6 weeks of age, the first sign of lymphocyte infiltration in hyperplastic islets was observed at 15 weeks of age-i.e., several weeks after the previously estimated time of onset of endogenous Tag expression (5) . The number of infiltrated islets increased gradually with the age of the mice. By the time these mice succumbed with insulinomas (16-28 months ofage), most islets had become hyperplastic and >50%o ofthe hyperplastic islets exhibited insulitis (Fig. 3C) . However, no lymphocyte infiltration was observed in insulinomas (Fig.  3D) . Similar (Table 2) , similarto thatoftheir (Am-heterozygous littermates (Tag4; A32m+/p2m-) and the same as that of the historical RIPl-Tag4 controls (see Table  1 ). This genetic approach clearly shows that immune surveillance by major histocompatibility complex (MHC) class I-restricted T cells is not a factor that affects tumorigenesis in RIP1-Tag4 mice.
Expression of SV40 T Antigen Can Be Detected in 5-WeekOld RIP1-Tag4 Mice. To examine the mechanism whereby immunization of RlP1-Tag4 mice at 3 weeks of age might delay tumor appearance, whereas immunization at 9 weeks of age is ineffectual, we analyzed the onset of endogenous Tag expression, previously estimated by immunohistochemical analysis to occur at 10-12 weeks of age (7) . Total pancreatic RNA was extracted from RIP1-Tag4 mice at 1-9 weeks of age, reverse-transcribed into cDNA, and amplified by PCR with a set ofprimers specific for SV40 Tag coding sequences. Relatively strong Tag-specific signals were detected in pancreata from RIP1-Tag4 mice at 7-9 weeks of age, and weaker signals were seen in samples from 5-to 6-week-old mice. In mice of s4 weeks, no Tag expression was detected, although the product from actin primers was clearly detectable in these samples (Fig. 4A) .
Although RIP-controlled transgenes are expressed predominantly in pancreatic P cells, some lineages of mice express them in other tissues, such as cells of neural crest origin in RIP1-Tag2 mice (6) and thymic cells in RIP-Kb mice (18) . To confirm that the in vivo unresponsiveness of Tagspecific CTLs in RIP1-Tag4 mice was not induced by the thymic expression of the transgene, we isolated thymic RNA from RIP1-Tag2 and RIP1-Tag4 mice at 3 and 6 weeks of age, respectively, and reverse-transcribed and amplified the RNA by using Tag-specific primers. Thymic expression ofTag was detected in RIP1-Tag2 but not RIP1-Tag4 mice (Fig. 4B) . Insulinoma Cells from Immunized RIP1-Tag4 Mice Express Reduced Levels of MHC Class I Antigen. Although Taginduced insulinoma development was significantly delayed by SV40 infection of RIP1-Tag4 mice prior to endogenous expression of Tag, these animals eventually succumbed with insulinomas. To address a possible mechanism that might explain this finding, we investigated MHC class I expression on insulinoma cells derived from these mice. Tumor cell suspensions were prepared from freshly isolated solid insulinomas, immunotagged with antibody to H-2Kb and analyzed by FACS. Islet cells from normal C57BL/6J mice and from immunized RIP1-Tag4 mice were also isolated and similarly analyzed. Insulinomas from RIP1-Tag4 mice generally expressed very low levels of MHC class I antigen as compared with normal islet cells, whereas islet cells from 10-month-old RIP1-Tag4 mice immunized at 3 weeks of age expressed much more MHC class I antigen than did normal islets (Fig.  5 ). These findings, together with the histologic investigation indicating lymphocytic infiltration in 50% of islets from Control (P3X) SV40-infected mice (Fig. 3C) , suggest that local production of cytokines by infiltrating lymphocytes might influence the level of MHC class I antigen expressed on these cells. That the insulinomas express even less class I antigen than do normal islet cells suggests that down-regulation ofMHC class I gene expression may accompany tumor progression.
DISCUSSION
The RIP1-Tag transgenic mouse provides a system to elucidate not only the mechanisms governing immune recognition of self, but also to establish the effect of immune tolerance or recognition on tumor growth. We find that RIP1-Tag2 mice are profoundly tolerant to the transgene product. Since Tag is expressed in the thymus during T-cell repertoire formation, deletional tolerance, such as that exhibited in other Tagtransgenic lineages (3, 4) , appears a likely mechanism to account for the immunologic nonresponsiveness in this lineage. On the other hand, that lymphocytes from RIP1-Tag4 mice mount an active Tag-specific CTL response suggests that Tag-specific T-cell precursors are neither deleted nor permanently anergized in RIP1-Tag4 mice. Nonetheless, RIP1-Tag4 animals develop Tag-induced tumors despite the presence of T cells that, after in vivo stimulation by SV40 infection, are able to recognize and destroy SV40-transformed target cells in vitro. Indeed, RIP1-Tag4 mice succumb with tumors at the same time of life as Tag4 P2m-deficient mice, which are genetically incapable of mounting an effective MHC class I-restricted CTL response. We therefore suggest that the Tag-specific CTLs in the periphery of RIP1-Tag4 mice are unable to respond to Tag presented on islet (3 cells. A similar phenomenon has been observed in several other transgenic lineages, such as the E Eb, Ad-, and Ak-transgenic mice that express the MHC class II genes on pancreatic P cells (19) (20) (21) . In each of these cases, the mice exhibited active mixed-lymphocyte reactions to the transgene product in vitro but did not generate an in vivo autoimmune response, suggesting that the transgene product expressed on , islet cells may be presented in a way that usually results in in vivo unresponsiveness rather than activation of the transgene-specific T cells in the periphery.
By correlating the outcome of SV40 infection with the average developmental time of Tag expression in RIP1-Tag4 mice, we find that in vivo unresponsiveness to Tag is established upon the onset of transgene expression. RT Relative f luorescence intensity (18, 25) . Although it is difficult to completely rule out this possibility, RT-PCR amplification showed no indication that Tag was expressed in RIP1-Tag4 thymus. Furthermore, lymphocytes from RIP1-Tag4, but not nontransgenic, mice were able to mature into active CTLs without in vivo priming, a fact difficult to explain by any deletion model. In this respect, our results are consistent with a mechanism of extrathymic tolerance with inactivation of self-reactive CD8+ T cells (26, 27) . The absence of expression of costimulatory molecules, on islet P cells, or the lack of appropriate activation signals, such as interleukin 2, may account for their inability to initiate a primary T-cell response (28, 29) . The inappropriate presentation of Tag may result in an unresponsive state among Tag-specific CTL precursors. It has been shown in another system that the establishment and maintenance of in vivo unresponsiveness require continual exposure of the T cells to antigens (30 
